Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: TARGETED THERAPY, . Treffer: 80

2020

Hansmann, G; Apitz, C; Humpl, T; Koestenberger, M; Michel-Behnke, I; Schulze-Neick, I; Quandt, D; Lammers, AE Urgent need for off-label use of PAH medications and reimbursement for children with pulmonary hypertension Statement of the Working Group on Pulmonary Hypertension of the German Society for Pediatric Cardiology and Congenital Cardiac Defects (DGPK)
MONATSSCHR KINDERH. 2020;
Web of Science FullText FullText_MUG

 

Richtig, E The therapeutic landscape of advanced melanoma
MEMO-MAG EUR MED ONC. 2020;
Web of Science FullText FullText_MUG

 

Roessner, A; Smolle, M; Haybäck, J [Giant cell tumor of bone : Morphology, molecular pathogenesis, and differential diagnosis].
Pathologe. 2020; 41(2):134-142
Web of Science PubMed FullText FullText_MUG

 

Skálová, A; Banečkova, M; Thompson, LDR; Ptáková, N; Stevens, TM; Brcic, L; Hyrcza, M; Michal, M; Simpson, RHW; Santana, T; Michal, M; Vaněček, T; Leivo, I Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Am J Surg Pathol. 2020; 9(3):
PubMed FullText FullText_MUG

 

2019

Bakhtiar, S; Fekadu, J; Seidel, MG; Gambinieri, E Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders.
Front Pediatr. 2019; 7: 461-461. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bollerslev, J; Schalin-Jantti, C; Rejnmark, L; Siggelkow, H; Morreau, H; Thakker, RV; Sitges-Serra, A; Cetani, F; Marcocci, C; PARAT Workshop Group MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.
EUR J ENDOCRINOL. 2019; 181(3): P1-P19. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Denk, H; Stumptner, C; Abuja, PM; Zatloukal, K Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Expert Opin Ther Targets. 2019; 23(5):393-406
Web of Science PubMed FullText FullText_MUG

 

Hochmair, MJ; Weinlinger, C; Fabikan, H; Illini, O; Krenbek, D; Setinek, U; Watzka, S; Koger, R; Meilinger, M; Absenger, G; Wanke, M; Semmelweis, C; Rauter, M; Valipour, A Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
J THORAC ONCOL. 2019; 14(10):S847-S847. [Poster]
Web of Science FullText FullText_MUG

 

Jenks, JD; Mehta, SR; Hoenigl, M Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?
Med Mycol. 2019; 57(Supplement_2): S168-S178.
Web of Science PubMed FullText FullText_MUG

 

Mahmoudian, J; Ghods, R; Nazari, M; Jeddi-Tehrani, M; Ghahremani, MH; Ghaffari-Tabrizi-Wizsy, N; Ostad, SN; Zarnani, AH PLAC1: biology and potential application in cancer immunotherapy.
Cancer Immunol Immunother. 2019; 68(7): 1039-1058.
Web of Science PubMed FullText FullText_MUG

 

Mohrherr, J; Haber, M; Breitenecker, K; Aigner, P; Moritsch, S; Voronin, V; Eferl, R; Moriggl, R; Stoiber, D; Győrffy, B; Brcic, L; László, V; Döme, B; Moldvay, J; Dezső, K; Bilban, M; Popper, H; Moll, HP; Casanova, E JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression.
Int J Cancer. 2019; 145(12):3376-3388 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ott, SR; Meier, N; Kolditz, M; Bauer, TT; Rohde, G; Presterl, E; Schürmann, D; Lepper, PM; Ringshausen, FC; Flick, H; Leib, SL; Pletz, MW; OPINION Study Group Pulmonary nocardiosis in Western Europe-Clinical evaluation of 43 patients and population-based estimates of hospitalization rates.
INT J INFECT DIS. 2019; 81(2): 140-148. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pichler, R; Compérat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Cancers (Basel). 2019; 11(3): 422 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Scheipl, S; Liegl-Atzwanger, B; Szkandera, J; Rinner, B; Viertler, C; Friesenbichler, J; Bergovec, M; Leithner, A [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Orthopade. 2019; 48(9): 776-783. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498
Web of Science PubMed FullText FullText_MUG

 

2018

Berger, M; Richtig, G; Kashofer, K; Aigelsreiter, A; Richtig, E The window of opportunities for targeted therapy in BRAFwt/NRASwt/KITwt melanoma: biology and clinical implications of fusion proteins and other mutations.
G Ital Dermatol Venereol. 2018; 153(3): 349-360. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klimek, L; Sperl, A; Becker, S; Mösges, R; Tomazic, PV Current therapeutical strategies for allergic rhinitis.
Expert Opin Pharmacother. 2018; 12(2): 1-7.
Web of Science PubMed FullText FullText_MUG

 

Kriegshäuser, G; Enko, D; Novy, M; Reitmayr, A; Loidl, A; Halwachs-Baumann, G; Oberkanins, C EGFR Mutational Profiling in Non-Small Cell Lung Cancer: The Clinical Performance of a Sensitive Reverse-Hybridization Assay.
Appl Immunohistochem Mol Morphol. 2018; 26(6):388-392
Web of Science PubMed FullText FullText_MUG

 

Ryska, A; Berzinec, P; Brcic, L; Cufer, T; Dziadziuszko, R; Gottfried, M; Kovalszky, I; Olszewski, W; Oz, B; Plank, L; Timar, J NSCLC molecular testing in Central and Eastern European countries.
BMC Cancer. 2018; 18(1): 269-269. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zboray, K; Mohrherr, J; Stiedl, P; Pranz, K; Wandruszka, L; Grabner, B; Eferl, R; Moriggl, R; Stoiber, D; Sakamoto, K; Wagner, KU; Popper, H; Casanova, E; Moll, HP AKT3 drives adenoid cystic carcinoma development in salivary glands.
Cancer Med. 2018; 7(2):445-453 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zhou, Q; Eldakhakhny, S; Conforti, F; Crosbie, EJ; Melino, G; Sayan, BS Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation.
Cell Death Dis. 2018; 9(5):504-504 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Abbasi, MR; Rifatbegovic, F; Brunner, C; Mann, G; Ziegler, A; Pötschger, U; Crazzolara, R; Ussowicz, M; Benesch, M; Ebetsberger-Dachs, G; Chan, GCF; Jones, N; Ladenstein, R; Ambros, IM; Ambros, PF Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.
Clin Cancer Res. 2017; 23(15):4224-4232 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Deinlein, T; Wolf, IH; Rainer, B; Kupsa, R; Richtig, E; Hofmann-Wellenhof, R; Zalaudek, I Treatment of Primary and Metastatic Multifocal Mucosal Melanoma of the Oral Cavity with Imatinib.
Case Rep Oncol. 2017; 10(2):558-563 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fakhruddin, N; Jabbour, M; Novy, M; Tamim, H; Bahmad, H; Farhat, F; Zaatari, G; Aridi, T; Kriegshauser, G; Oberkanins, C; Mahfouz, R BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases.
Sci Rep. 2017; 7(1):4666-4666 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, JJ; Nathan, P; Dummer, R; Forsea, AM; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Kukushkina, M; De La Cruz Merino, L; Ymeri, A; Risteski, M; Garbe, C More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Eur J Cancer. 2017; 75(4):313-322
Web of Science PubMed FullText FullText_MUG

 

Meiri, H; Osol, G; Cetin, I; Gizurarson, S; Huppertz, B Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.
Comput Struct Biotechnol J. 2017; 15(10):433-446 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ofner, R; Ritter, C; Ugurel, S; Cerroni, L; Stiller, M; Bogenrieder, T; Solca, F; Schrama, D; Becker, JC Non-reproducible sequence artifacts in FFPE tissue: an experience report.
J Cancer Res Clin Oncol. 2017; 143(7):1199-1207 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rinner, B; Gandolfi, G; Meditz, K; Frisch, MT; Wagner, K; Ciarrocchi, A; Torricelli, F; Koivuniemi, R; Niklander, J; Liegl-Atzwanger, B; Lohberger, B; Heitzer, E; Ghaffari-Tabrizi-Wizsy, N; Zweytick, D; Zalaudek, I MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
Sci Rep. 2017; 7(1):2098-2098 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Szkandera, J ASCO update - what is new in the systemic treatment of advanced soft tissue sarcomas?
MEMO-MAG EUR MED ONC. 2017; 10(4): 233-236.
Web of Science FullText FullText_MUG

 

Wagener, N; Edelmann, D; Benner, A; Zigeuner, R; Borgmann, H; Wolff, I; Krabbe, LM; Musquera, M; Dell'Oglio, P; Capitanio, U; Klatte, T; Cindolo, L; May, M; Brookman-May, SD; European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
PLOS ONE. 2017; 12(9): e0184173-e0184173. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Czink, E; Heining, C; Weber, TF; Lasitschka, F; Schemmer, P; Schirmacher, P; Weiss, KH; Glimm, H; Brors, B; Weichert, W; Jäger, D; Fröhling, S; Springfeld, C [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Z Gastroenterol. 2016; 54(5):426-430
Web of Science PubMed FullText FullText_MUG

 

Delcroix, M; Lang, I; Pepke-Zaba, J; Jansa, P; D'Armini, AM; Snijder, R; Bresser, P; Torbicki, A; Mellemkjaer, S; Lewczuk, J; Simkova, I; Barberà, JA; de Perrot, M; Hoeper, MM; Gaine, S; Speich, R; Gomez-Sanchez, MA; Kovacs, G; Jaïs, X; Ambroz, D; Treacy, C; Morsolini, M; Jenkins, D; Lindner, J; Dartevelle, P; Mayer, E; Simonneau, G Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.
CIRCULATION. 2016; 133(9): 859-871. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hofman, P; Popper, HH Pathologists and liquid biopsies: to be or not to be?
Virchows Arch. 2016; 469(6):601-609
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Zombirt, E; Trapp, E; Jückstock, J; Andergassen, U; Neugebauer, J; Kost, B; Weissenbacher, T; Jeschke, U; Schindlbeck, C; Janni, W; Alunni-Fabbroni, M Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Oncology. 2016; 90(4):232-238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281
Web of Science PubMed FullText FullText_MUG

 

Stanta, G; Jahn, SW; Bonin, S; Hoefler, G Tumour heterogeneity: principles and practical consequences.
Virchows Arch. 2016; 469(4):371-384
Web of Science PubMed FullText FullText_MUG

 

Taucher, V; Mangge, H; Haybaeck, J Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
Cell Oncol (Dordr). 2016; 39(4):295-318 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wiesner, T; Kutzner, H; Cerroni, L; Mihm, MC; Busam, KJ; Murali, R Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Pathology. 2016; 48(2):113-131 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Woltsche, N; Schwab, C; Deinlein, T; Hofmann-Wellenhof, R; Zalaudek, I Dermoscopy in the era of dermato-oncology: from bed to bench side and retour.
Expert Rev Anticancer Ther. 2016; 16(5):531-541
Web of Science PubMed FullText FullText_MUG

 

Zhang, F; Li, M; Wang, J; Liang, X; Su, Y; Wang, W Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs.
AAPS PharmSciTech. 2016; 17(3): 539-552.
Web of Science PubMed FullText FullText_MUG

 

2015

Calabrese, F; Lunardi, F; Popper, H Molecular diagnosis in lung diseases.
Front Biosci (Landmark Ed). 2015; 20(12):644-688
Web of Science PubMed FullText FullText_MUG

 

Kump, P; Suppan, C; Spindelbock, W; Krejs, G; Lipp, R Fifty-Three Year-Old-Male with a Symptomatic Ileocecal Carcinoid: An Individual Follow-Up of 14 Yrs with 5 Different Anti-Proliferative Therapies
NEUROENDOCRINOLOGY. 2015; 102(1-2):151-151.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Obenauf, AC; Zou, Y; Ji, AL; Vanharanta, S; Shu, W; Shi, H; Kong, X; Bosenberg, MC; Wiesner, T; Rosen, N; Lo, RS; Massagué, J Therapy-induced tumour secretomes promote resistance and tumour progression.
Nature. 2015; 520(7547): 368-372. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ramlau, R; Cufer, T; Berzinec, P; Dziadziuszko, R; Olszewski, W; Popper, H; Bajcic, P; Dusšk, L; Zbozinkova, Z; Pirker, R; INSIGHT study team Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study.
J Thorac Oncol. 2015; 10(9):1370-1374 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, S; Leber, R; Rinner, B; Schaider, H; Lohner, K; Zweytick, D Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
Biochim Biophys Acta. 2015; 1848(11 Pt A):2918-2931 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

2014

Fröhlich, E; Wahl, R The current role of targeted therapies to induce radioiodine uptake in thyroid cancer.
CANCER TREAT REV. 2014; 40(5): 665-674.
Web of Science PubMed FullText FullText_MUG

 

Peacock, AJ; Crawley, S; McLure, L; Blyth, KG; Vizza, CD; Poscia, R; Francone, M; Iacucci, I; Olschewski, H; Kovacs, G; Vonk Noordegraaf, A; Marcus, JT; van de Veerdonk, MC; Oosterveer, FP Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study.
Circ Cardiovasc Imaging. 2014; 7(1):107-114 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum